Prashant Vempati is an Oncology physician. OpenAlex indexes 56 publications with 1,333 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 10th Ave
Suite 3a-15
New York, NY 100191147
Telephone
212-523-4000Provider last certified this registry record 4 May 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Telix PharmaceuticalsProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Novocure Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
59.5%Corticosteroid59.5%Dexamethasone100%Part D≥20 patientsMetabolism & gastrointestinal
40.5%Proton pump inhibitor40.5%Pantoprazole Sodium100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Navigating the Complexities of Skull Base Paragangliomas: Case Report and Overview with Emphasis on Multi-Disciplinary Approach to Diagnosis and Management
Journal of Neurological Surgery Part B Skull Base
2026 - High-grade glioma with dural progression: A single-center case series and review of literature
Radiology Case Reports
2026 - Signal-Seeking P2R Trial of Proton or IMRT Dose Intensification in GBM: NRG-BN001
International Journal of Radiation Oncology*Biology*Physics
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”